Clene logo

Clene Share Price (NASDAQ: CLNN)

$5.36

-0.05

(-0.92%)

Last updated on

Check the interactive Clene Stock chart to analyse performance

Clene stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$5.30
    Today's High:$5.42

    Day's Volatility :2.21%

  • 52 Weeks Low:$2.28
    52 Weeks High:$6.90

    52 Weeks Volatility :66.96%

Clene Stock Returns

PeriodClene IncSector (Health Care)Index (Russel 2000)
3 Months
10.61%
3.6%
0.0%
6 Months
25.17%
-7.7%
0.0%
1 Year
-8.45%
-12.6%
0.0%
3 Years
-90.69%
9.5%
-4.7%

Clene Inc Key Stats

Check Clene key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$5.41
Open
$5.35
Today's High
$5.42
Today's Low
$5.3
Market Capitalization
$54.0M
Today's Volume
$33.0K
52 Week High
$6.9
52 Week Low
$2.2801
Revenue TTM
$286.0K
EBITDA
$-24.8M
Earnings Per Share (EPS)
$-3.78
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.61%
Return On Equity TTM
-1738.36%

Stock Returns calculator for Clene Stock including INR - Dollar returns

The Clene stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Clene investment value today

Current value as on today

₹1,06,992

Returns

₹6,992

(+6.99%)

Returns from Clene Stock

₹1,708 (+1.71%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Clene Stock

-23%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Clene Stock from India on INDmoney has decreased by -23% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Clene Stock

Rating
Trend

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Clene(by analysts ranked 0 to 5 stars)

Clene Share Price Target

What analysts predicted

Upside of 473.03%

Target:

$30.71

Current:

$5.36

Clene share price target is $30.71, a slight Upside of 473.03% compared to current price of $5.36 as per analysts' prediction.

Clene Stock Insights

  • Price Movement

    In the last 1 month, CLNN stock has moved up by 55.3%
  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 91.0K → 27.0K (in $), with an average decrease of 38.8% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -751.0K → -7.41M (in $), with an average decrease of 887.9% per quarter
  • CLNN vs K (3 yr)

    In the last 3 years, Kellanova has given 8.6% return, outperforming this stock by 99.5%

Clene Technicals Summary

Sell

Neutral

Buy

Clene is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Clene Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Clene Inc logo
55.3%
25.17%
-8.45%
-90.69%
-96.99%
Jbs Nv logo
17.99%
16.8%
16.8%
16.8%
16.8%
Kraft Heinz Company, The logo
1.88%
-10.68%
-21.4%
-25.8%
-18.06%
Mccormick & Company, Incorporated logo
-0.35%
-16.93%
-13.32%
-16.99%
-31.64%
General Mills, Inc. logo
0.7%
-20.53%
-32.09%
-36.07%
-21.86%
Kellanova logo
-0.46%
-3.81%
-0.87%
8.34%
14.76%

About Clene Inc

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a second Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases. The company develops CNM-AgZn17, a gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to support wound healing; and CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat infection disease and to provide immune support for symptom resolution. In addition, it markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement; and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. The company is headquartered in Salt Lake City, Utah.
Organization
Clene
Employees
75
CEO
Mr. Robert Etherington MBA
Industry
Consumer Defensive

Key Management of Clene Inc

NameTitle
Mr. Robert Etherington MBA
CEO, President & Director
Mr. Morgan R. Brown CPA, M.B.A.
Chief Financial Officer
Mr. Mark G. Mortenson ESQ.
Chief Science Officer
Mr. Jerry Miraglia J.D.
General Counsel & Corporate Secretary
Ms. Mary Anne Mcneil
Head of Human Resources
Mr. Michael T. Hotchkin
Chief Development Officer
Dr. Benjamin M. Greenberg M.D., M.H.S.
Head of Medical

Important FAQs about investing in CLNN Stock from India :

What is Clene share price today?

Clene share price today is $5.36 as on at the close of the market. Clene share today touched a day high of $5.42 and a low of $5.30.

What is the 52 week high and 52 week low for Clene share?

Clene share touched a 52 week high of $6.90 and a 52 week low of $2.28. Clene stock price today i.e. is closed at $5.36, lower by 22.32% versus the 52 week high.

How to invest in Clene Stock (CLNN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Clene on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Clene Shares that will get you 0.2799 shares as per Clene share price of $5.36 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Clene Stock (CLNN) from India?

Indian investors can start investing in Clene (CLNN) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Clene stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Clene share’s latest price of $5.36 as on August 30, 2025 at 1:29 am IST, you will get 1.8657 shares of Clene. Learn more about fractional shares .

What are the returns that Clene has given to Indian investors in the last 5 years?

Clene stock has given -96.99% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?